Press release
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market 2016 - 2022
A sample of this report is available upon request @
http://www.persistencemarketresearch.com/samples/10097
Chemotherapy induced acryl erythema is a dose dependent condition, regression of which can be achieved by discontinuation of chemotherapy or by dose reduction. Treatment for chemotherapy induced acryl erythema includes symptomatic treatment with analgesics and antihistaminic drugs to reduce pain and edema.
Surge in usage of chemotherapeutic agents due to increasing incidence of cancers is the major growth driver of global chemotherapy induced acral erythema treatment market. According to WHO cancer factsheet 2015, the worldwide incidence of cancers is expected to increase by 70% in next 2 decades which perhaps influence the growth of global chemotherapy induced acral erythema treatment market over the forecast period from 2016–2026.
Moreover, lifestyle up-gradation, increasing number of smokers are some secondary considerations accountable for rise in global chemotherapy induced acral erythema treatment market.
The global chemotherapy induced acral erythema treatment market has been segmented on the basis of product type, retail sales channels and geography.
To view TOC of this report is available upon request @
http://www.persistencemarketresearch.com/toc/10097
The global chemotherapy induced acral erythema treatment market is highly fragmented with large number of local as well as global players. Being the first line therapy for acryl erythema, analgesics segment is expected to contribute for major portion in global chemotherapy induced acral erythema treatment market.
Study results from Valencia Institute of Cancer suggests that there is 2% incidence of chemotherapy induced acral erythema among cancer patients who are treated with chemotherapy in Europe.
Geographically, the global chemotherapy induced acral erythema treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to contribute a major share in global chemotherapy induced acral erythema treatment market owing to increased usage of gemcitabine, a common cause of acral erythema.
Emerging new indications of some drugs and new therapies for the treatment of chemotherapy induced acral erythema such as topical sildenafil, nicotine patches, topical allopurinol and others are expected to launch in market within the forecast period, which are expected to boost the growth of global chemotherapy induced acral erythema treatment market.
Some of the major players in the global chemotherapy induced acral erythema treatment market include Taro Pharmaceutical Industries Ltd., Oceanside Pharmaceuticals, Inc., Pfizer, Novartis AG, A-S Medication Solutions, LLC., Preferred Pharmaceuticals, Inc., Syntex Pharmaceuticals Inc., Valeant Canada LP, Technilab Pharma, Inc., Allergan, Plc. And others.
Buy Now: You can now buy a single user license of the report @
http://www.persistencemarketresearch.com/checkout/10097
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market 2016 - 2022 here
News-ID: 684003 • Views: …
More Releases from Persistence Market Research
Global Supply Chain Management BPO Market to Reach US$ 58 Bn by 2032
The Supply Chain Management BPO Market is experiencing a transformative phase as businesses increasingly recognize the strategic advantages of outsourcing non-core supply chain operations. The global market is forecast to grow at a CAGR of 8.6%, expanding from US$32.5 billion in 2025 to reach approximately US$58 billion by 2032. Supply chain management business process outsourcing (BPO) refers to the practice of delegating comprehensive supply chain operations-ranging from procurement, logistics, inventory…
Healthcare Cloud Computing Market to Reach US$ 197.4 Bn by 2032 at 17.3% CAGR
Overview of the Healthcare Cloud Computing Market
The global healthcare cloud computing market is poised for significant expansion, with an estimated valuation of US$63.5 billion in 2025, projected to reach US$197.4 billion by 2032 at a robust CAGR of 17.3%. This rapid growth is largely fueled by the increasing adoption of cloud infrastructure to enhance data accessibility, facilitate telehealth services, and integrate artificial intelligence (AI) into healthcare analytics. Healthcare organizations are…
Global Big Data Storage Market to Grow at 13% CAGR Through 2032
The global storage in big data market is undergoing a transformative expansion as organizations generate and process massive volumes of data from diverse sources such as IoT devices, digital transactions, and connected platforms. The market is projected to be valued at US$63.4 billion in 2025 and is anticipated to reach US$132 billion by 2032, registering an impressive CAGR of 13% during the forecast period (2025-2032). This growth is primarily driven…
U.S. Internet of Things (IoT) Market to Reach $609.2 Billion by 2032, Driven by …
The U.S. Internet of Things (IoT) market is experiencing rapid growth, driven by accelerating digital transformation across industries and increasing adoption of connected devices. Valued at US$ 142.2 billion in 2024, the market is expected to reach US$ 169.0 billion in 2025 and further expand at an impressive CAGR of 20.1% to reach US$ 609.2 billion by 2032. The United States currently accounts for nearly 20% of the global IoT…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
